Product Program year 2023 Source: CMS Open Payments

Photrexa Cross-Linking Kit

Drug Glaucoma

Open in the dashboard

General payments

$8,850

102 payments

Research payments

$0

0 payments

Through program year 2023, $8,850 in general payments and $0 in research payments were reported against Photrexa Cross-Linking Kit (Glaucoma).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $8,850 102

Breakdown

Who paid General payments · program year 2023
  1. Glaukos Corporation $8,850 102 payments
Top recipients General payments · program year 2023
  1. James Flickinger Optometrist · Scranton, PA $788 9% · 2 payments
  2. Michael Boland Optometrist · Clarks Summit, PA $788 9% · 2 payments
  3. Mark Price Optometrist · Visalia, CA $175 2% · 1 payment
  4. Michael Boone Ophthalmology · Visalia, CA $175 2% · 1 payment
  5. Michael Henry Ophthalmology · Visalia, CA $175 2% · 1 payment

The top 5 of 97 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Optometrist $5,368 62% · 54 practitioners
  2. Ophthalmology $2,968 34% · 37 practitioners
  3. Retina Specialist Ophthalmology $110 1% · 1 practitioner
  4. Cornea and External Diseases Specialist Ophthalmology $108 1% · 1 practitioner
  5. Physician Assistant $95 1% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $2,023 23% · 15 recipients
  2. Pennsylvania $1,695 19% · 7 recipients
  3. Louisiana $1,157 13% · 13 recipients
  4. Nebraska $1,079 12% · 17 recipients
  5. Missouri $700 8% · 12 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

102 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record